冠状动脉CT血管成像增强后肝脏衰减机会性检出肝脂肪变
回顾性纳入300例行CCTA并同期平扫Agatston评分成人,以平扫肝衰减<40 HU定义中重度肝脂肪变(占36.3%)。增强后肝衰减在100/120/140 kVp下AUC分别为0.88/0.95/0.89,最佳阈值随管电压升高而降低(54/47/40 HU)。肝脂肪变与冠脉钙化负荷相关,但与CAD-RADS分类分布无关。
要点
- CCTA增强后肝衰减可用于机会性筛查中重度肝脂肪变。
- 阈值随管电压变化:100/120/140 kVp对应54/47/40 HU。
- 肝脂肪变患者钙化评分0比例更低、101-300比例更高。
关键影像表现/征象
- 增强后肝衰减采用标准化感兴趣区测量。
- 肝脂肪变患者冠脉钙化评分为0的比例为43.7%,无脂肪变为57.6%。
诊断标准与关键数值
- 中重度肝脂肪变定义:平扫肝衰减<40 HU。
- 增强后肝衰减诊断中重度肝脂肪变的AUC:100 kVp为0.88,120 kVp为0.95,140 kVp为0.89。
- 最佳阈值随管电压升高而降低:100 kVp为54 HU,120 kVp为47 HU,140 kVp为40 HU。
临床应用与阅片要点
- 在CCTA增强图像上测量肝衰减可机会性提示中重度肝脂肪变,但需按管电压选用对应阈值。
- 肝脂肪变与冠脉钙化负荷相关,阅片时可提示临床关注代谢风险,但不影响CAD-RADS分类。
局限性
- 回顾性单中心设计。
- 仅评估中重度肝脂肪变,未覆盖轻度脂肪变。
- 增强后肝衰减阈值需按管电压调整,直接套用单一阈值可能误判。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Purpose To evaluate the diagnostic performance of postcontrast liver attenuation measured with coronary CT angiography (CCTA) for opportunistic detection of hepatic steatosis and to assess the impact of tube potential variation on optimal attenuation thresholds and overall performance. Materials and Methods This retrospective study included adult patients who underwent CCTA with concomitant unenhanced coronary Agatston scoring (January to December 2025). Moderate-to-severe hepatic steatosis was defined as unenhanced liver attenuation less than 40 HU. Postcontrast liver attenuation was measured using standardized regions of interest. Diagnostic performance was assessed using receiver operating characteristic analysis with Youden index-based threshold determination. Associations between hepatic steatosis, Agatston score categories, and Coronary Artery Disease Reporting and Data System (CAD-RADS) categorizations were evaluated using likelihood ratio χ2 tests. Results Among 300 included patients (mean age ± SD, 55.6 years ± 12.0; 170 males), moderate-to-severe steatosis was present in 109 patients (36.3%). Postcontrast liver attenuation demonstrated high diagnostic performance across all settings (area under the receiver operating characteristic curve: 0.88, 0.95, and 0.89 at 100, 120, and 140 kVp, respectively). Optimal thresholds decreased with increasing tube potential (54, 47, and 40 HU at 100, 120, and 140 kVp, respectively). Patients with steatosis had a lower frequency of coronary artery calcium scores of zero (43.7% vs 57.6%) and a higher frequency of coronary artery calcium scores of 101-300 (11.7% vs 4.9%; P = .042), whereas CAD-RADS distribution was similar (P = .12). Conclusion Postcontrast liver attenuation measured with CCTA demonstrated promising diagnostic performance for opportunistic identification of moderate-to-severe hepatic steatosis across different tube potential settings. Hepatic steatosis was associated with coronary calcium burden but not with CAD-RADS categorization. Keywords: CT-Coronary Angiography, Abdomen/GI, Coronary Arteries, Liver Supplemental material is available for this article. © RSNA, 2026.
引用
- Karahacioglu D, Cural Kula G, Kula S, et al. Opportunistic Detection of Hepatic Steatosis Using Postcontrast Liver Attenuation at Coronary CT Angiography. Radiol Cardiothorac Imaging. 2026. PMID: 42878641. doi:10.1148/ryct.260148
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。